President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Patient PortalAdult ClinicPediatricsEye CareMake an AppointmentBillingInfo for Healthcare Professionals
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Research Findings

Five groups of patients enrolled in the Why WAIT program were studied, for a total of 62 participants (22 men and 40 women). They had an average age of 56.1+1.4 years (mean±SE), diabetes duration of 7.2+0.8 years, and a BMI of 38.3+0.69 kg/m2 Over 12 weeks, participants lost an average of 23.5+1.2 lbs or 9.8+0.4% of their initial body weight (p<0.001) and 3.7+0.3 inches from their waist circumference (p<0.001). HbA1c decreased from 7.26+0.17% to 6.37+0.11% (p<0.001). Total cholesterol decreased by 12.2+1.8% (p<0.001), triglyceride by 21.8+3.8% (p<0.01) and LDL by 11.4+3.0 % (p<0.001). C-reactive protein (CRP) decreased from 6.0+0.85 to 4.2+0.65 mg/L (p<0.01). CRP reduction correlated with the percentage of weight and fat loss (p<0.05).

Participants were able to maintain the achieved weight loss for another six months after the program with the help of the support sessions.

Page last updated: October 23, 2016